Tuesday, November 17, 2020 10:42:24 AM
I think that this stock will be a bigger.
LOW float.COULD EXPLODE in any time
Recent CMPS News
- Compass Pathways nimmt am Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit teil • Business Wire • 09/24/2024 08:43:00 AM
- Compass Pathways participera au Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit • Business Wire • 09/24/2024 08:42:00 AM
- Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit • Business Wire • 09/23/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 12:26:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 10:31:15 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 10:30:44 AM
- Compass Pathways announces second quarter 2024 financial results and business highlights • GlobeNewswire Inc. • 08/01/2024 10:30:00 AM
- Compass Pathways appoints Lori Englebert as Chief Commercial Officer • GlobeNewswire Inc. • 06/26/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:22:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:21:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 10:46:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 10:44:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 10:44:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:28:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 10:46:27 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 10:45:59 AM
- Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights • GlobeNewswire Inc. • 05/08/2024 10:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 10:34:00 AM
- Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder • GlobeNewswire Inc. • 05/08/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 10:31:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 10:30:53 PM
- Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment • GlobeNewswire Inc. • 05/02/2024 10:30:00 AM
- Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression • GlobeNewswire Inc. • 04/29/2024 10:30:00 AM
- Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors • GlobeNewswire Inc. • 03/28/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:06:24 PM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM